Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Breast cancer

  • You have access
    MicroRNA-6744-5p promotes anoikis in breast cancer and directly targets NAT1 enzyme
    Sharan Malagobadan, Chai San Ho and Noor Hasima Nagoor
    Cancer Biology & Medicine February 2020, 17 (1) 101-111; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0010
  • You have access
    Epithelial-mesenchymal transition status of circulating tumor cells in breast cancer and its clinical relevance
    Jiaojiao Zhou, Xuan Zhu, Shijie Wu, Jingxin Guo, Kun Zhang, Chunjing Xu, Huihui Chen, Yuxi Jin, Yuting Sun, Shu Zheng and Yiding Chen
    Cancer Biology & Medicine February 2020, 17 (1) 169-180; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0118
  • You have access
    Interpretation of breast cancer screening guideline for Chinese women
    Yubei Huang, Zhongsheng Tong, Kexin Chen, Ying Wang, Peifang Liu, Lin Gu, Juntian Liu, Jinpu Yu, Fengju Song, Wenhua Zhao, Yehui Shi, Hui Li, Huaiyuan Xiao and Xishan Hao
    Cancer Biology & Medicine November 2019, 16 (4) 825-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0322
  • You have access
    Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma
    Lijuan Li, Nan Wu, Fangxuan Li, Lingmei Li, Lijuan Wei and Juntian Liu
    Cancer Biology & Medicine February 2019, 16 (1) 139-146; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0035
  • You have access
    The PI3K/Akt/GSK-3β/ROS/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility
    Fengjiao Jin, Zhaozhen Wu, Xiao Hu, Jiahui Zhang, Zihe Gao, Xiao Han, Junfang Qin, Chen Li and Yue Wang
    Cancer Biology & Medicine February 2019, 16 (1) 38-54; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0253
  • You have access
    Comparison of sentinel lymph node detection performances using blue dye in conjunction with indocyanine green or radioisotope in breast cancer patients: a prospective single-center randomized study
    Long Yuan, Xiaowei Qi, Yi Zhang, Xinhua Yang, Fan Zhang, Linjun Fan, Li Chen, Kongyong Zhang, Ling Zhong, Yanling Li, Sijie Gan, Wenying Fu and Jun Jiang
    Cancer Biology & Medicine November 2018, 15 (4) 452-460; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0270
  • You have access
    ATM in breast and brain tumors: a comprehensive review
    Mehrdad Asghari Estiar and Parvin Mehdipour
    Cancer Biology & Medicine August 2018, 15 (3) 210-227; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0022
  • You have access
    Analysis of factors related to non-sentinel lymph node metastasis in 296 sentinel lymph node-positive Chinese breast cancer patients
    Amina Maimaitiaili, Di Wu, Zhenyu Liu, Haimeng Liu, Xiamusiye Muyiduli and Zhimin Fan
    Cancer Biology & Medicine August 2018, 15 (3) 282-289; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0023
  • You have access
    Benefit of everolimus as a monotherapy for a refractory breast cancer patient bearing multiple genetic mutations in the PI3K/AKT/mTOR signaling pathway
    Yehui Shi, Wenwen Zhang, Yingnan Ye, Yanan Cheng, Lei Han, Pengpeng Liu, Weipeng Zhao, Zhongsheng Tong and Jinpu Yu
    Cancer Biology & Medicine August 2018, 15 (3) 314-321; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0188
  • You have access
    Silencing of syndecan-binding protein enhances the inhibitory effect of tamoxifen and increases cellular sensitivity to estrogen
    Jun Zhang, Xiaolong Qian, Fangfang Liu, Xiaojing Guo, Feng Gu and Li Fu
    Cancer Biology & Medicine February 2018, 15 (1) 29-38; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0122

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire